Home/Endure Biotherapeutics/Gilbert Keller

GK

Gilbert Keller

Vice President of Preclinical Sciences

Endure Biotherapeutics

Therapeutic Areas

Metabolic Diseases Gastrointestinal Diseases

Endure Biotherapeutics Pipeline

Drug	Indication	Phase
Engineered Native Bacteria Platform	Phenylketonuria (PKU)	Pre-clinical

Leadership Team at Endure Biotherapeutics

Chief Executive Officer

Founder and Chief Medical Officer

Thomas (Ted) Daley

Member of the Board

View full Endure Biotherapeutics profile